If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFidelity Regulatory News (FSV)

Share Price Information for Fidelity (FSV)

Share Price is delayed by 15 minutes
Get Live Data
428.50    -0.50 (-0.12%)
Bid:
428.00
Ask:
429.00
Spread: 1.00 (0.234%)
Market Cap: £1.39b
FSV Live PriceLast checked at - London Stock Exchange

Intraday Fidelity Share Chart

Issue of Equity

22 Feb 2022 16:32

Fidelity Special Values Plc - Issue of Equity

Fidelity Special Values Plc - Issue of Equity

PR Newswire

London, February 22

Fidelity Special Values PLC

Issue of Ordinary Shares

On 22 February 2022, Fidelity Special Values PLC (the “Company”) issued from its block listing facility of 14 December 2020, a total of 175,000 new shares: 100,000 at a price of 291.50 pence per share and 75,000 at a price of 293.00 pence per share. These shares rank pari passu with the existing Ordinary shares in issue.

Following this issue, there are 1,555,000 Ordinary shares available under the Company’s block listing facility of 14 December 2020. In addition, the Company also has 30,000,000 ordinary shares under its block listing facility of 7 February 2022.

As a result of this issue, the total number of Ordinary shares in issue now stands at 323,458,920. There are no shares held in Treasury, therefore the total number of Ordinary shares with voting rights in the Company is 323,458,920.

The above figure of Ordinary shares with voting rights (323,458,920) may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.

Smita Amin

For and on behalf of FIL Investments International

Company Secretary

01737 836347

22 February 2022

Date   Source Headline
19th Mar 20247:00 amPRNNet Asset Value(s)
18th Mar 20247:00 amPRNNet Asset Value(s)
15th Mar 20247:00 amPRNNet Asset Value(s)
14th Mar 20247:00 amPRNNet Asset Value(s)
13th Mar 20247:00 amPRNNet Asset Value(s)
12th Mar 20247:00 amPRNNet Asset Value(s)
11th Mar 20247:00 amPRNNet Asset Value(s)
8th Mar 20247:00 amPRNNet Asset Value(s)
7th Mar 20247:00 amPRNNet Asset Value(s)
6th Mar 20247:00 amPRNNet Asset Value(s)
5th Mar 20245:40 pmPRNPortfolio Update
5th Mar 20247:00 amPRNNet Asset Value(s)
4th Mar 20247:00 amPRNNet Asset Value(s)
1st Mar 20244:08 pmPRNTotal Voting Rights
1st Mar 20247:00 amPRNNet Asset Value(s)
29th Feb 20247:00 amPRNNet Asset Value(s)
28th Feb 202412:06 pmPRNDirector/PDMR Shareholding
28th Feb 20247:00 amPRNNet Asset Value(s)
27th Feb 20247:00 amPRNNet Asset Value(s)
26th Feb 20247:00 amPRNNet Asset Value(s)
23rd Feb 20247:00 amPRNNet Asset Value(s)
22nd Feb 20249:57 amPRNMonthly Factsheet
22nd Feb 20247:00 amPRNNet Asset Value(s)
21st Feb 20247:00 amPRNNet Asset Value(s)
20th Feb 20247:00 amPRNNet Asset Value(s)
19th Feb 20247:00 amPRNNet Asset Value(s)
16th Feb 20247:00 amPRNNet Asset Value(s)
15th Feb 20247:00 amPRNNet Asset Value(s)
14th Feb 20247:00 amPRNNet Asset Value(s)
13th Feb 20247:00 amPRNNet Asset Value(s)
12th Feb 20247:00 amPRNNet Asset Value(s)
9th Feb 20247:00 amPRNNet Asset Value(s)
8th Feb 20247:00 amPRNNet Asset Value(s)
7th Feb 202410:19 amPRNBlocklisting - Interim Review
7th Feb 20247:00 amPRNNet Asset Value(s)
6th Feb 20247:00 amPRNNet Asset Value(s)
5th Feb 20247:00 amPRNNet Asset Value(s)
2nd Feb 20247:00 amPRNNet Asset Value(s)
1st Feb 20244:44 pmPRNTotal Voting Rights
1st Feb 20247:00 amPRNNet Asset Value(s)
31st Jan 20247:00 amPRNNet Asset Value(s)
30th Jan 20247:00 amPRNNet Asset Value(s)
29th Jan 20247:00 amPRNNet Asset Value(s)
26th Jan 20247:00 amPRNNet Asset Value(s)
25th Jan 20241:05 pmPRNMonthly Summary
25th Jan 20247:00 amPRNNet Asset Value(s)
24th Jan 20247:00 amPRNNet Asset Value(s)
23rd Jan 20247:00 amPRNNet Asset Value(s)
22nd Jan 20247:00 amPRNNet Asset Value(s)
19th Jan 20247:00 amPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.